AzTrials
AzTrials

Lumbar RadiculopathyDISC-PAINNCT05022251

Identifying Pain Generators and Potentiators of Residual Complaints Following Lumbar Discectomy

An observational study of Lumbar Radiculopathy and Central Sensitisation, run by University Ghent at 1 site in Belgium.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Lumbar discectomy (i.e. surgically removing a hernia) is frequently performed in Belgium to treat lumbar radiculopathy. Every year >12,000 interventions are performed with variable long-term results. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Lumbar Radiculopathy, Central Sensitisation
What is being tested?
Lumbar discectomy
Type of treatment
Surgery or procedure
How many people
1 participants
Where
1 siteBelgium
Study dates
1 Oct 2021to 31 Oct 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Lumbar radiculopathy patients scheduled for first-time, single level, unilateral lumbar discectomy. Sex, age, and BMI matched healthy controls.

Who may be able to join

  • Dutch speaking
  • Body mass index below 35kg/m²
  • Lumbar radiculopathy patients, classified as ASA I to II without any symptoms of spinal cord compression (i.e. bilateral leg pain), who are scheduled for a first-time, single-level, unilateral lumbar discectomy
  • Healthy, pain-free controls (score 0 on a visual analogue scale from 0 to 100)

Who cannot join

  • Female participants will be excluded if pregnant, lactating or <1 year postnatal
  • Having (a history) of severe medical disorders either respiratory (e.g. cystic fibrosis), orthopedic (e.g. whiplash trauma), neurologic (e.g. cerebrovascular incident), cardiovascular (e.g. severe hypertension), endocrinological (e.g. diabetes), psychiatric (e.g. post-traumatic stress disorder
  • Having a history of spinal surgery (e.g. discectomy), spinal traumata (e.g. vertebral fracture) or severe spinal deformities (e.g. spondylolisthesis)
  • Having a pacemaker or defibrillator
  • Healthy controls will be excluded if having suffered low back pain in the preceding year of score 2 or higher on the visual analog scale and which limited their activities of daily living or for which they consulted a (para)medic.

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • Ghent University (Hospital)

    Ghent

Other trials in Belgium

About this study

Lumbar discectomy (i.e. surgically removing a hernia) is frequently performed in Belgium to treat lumbar radiculopathy. Every year >12,000 interventions are performed with variable long-term results. The treatment success of this procedure varies and up to 41% of the patients report post-operative persistent pain complaints, and consequently suffer from failed back surgery syndrome (FBSS). Chronic complaints in FBSS following lumbar discectomy are usually treated with symptomatic interventions (including painkillers, neuromodulation, etc), rather than from a biopsychosocial perspective.

In order to develop a focused and effective treatment strategy, it is crucial to first gain insight into how persons with persistent complaints after lumbar discectomy differ from those without persistent symptoms. Different known contributing factors entail type of surgery, muscle and psychosocial impairments. Although in scientific and clinical literature it is assumed that dysfunctional pain processing also plays an important mechanistic role in FBSS, there is a lack of research to support this. However, this knowledge is crucial to depict the full mechanistic picture of pain generators and potentiators in FBSS.

Therefore, we will examine whether residual complaints persisting following lumbar discectomy can be accounted for by underlying dysfunctional pain processing and whether a clinical classification algorithm can be used to identify the predominant pain mechanism in these patients.

Being tested
Lumbar discectomy
Keywords
lumbar radiculopathy, discectomy, central sensitization
Medical subject headings
Radiculopathy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lumbar discectomyProcedure or surgery

    surgically removing a hernia

Study groups in NCT05022251
Study groupRoleWhat they receive
Lumbar radiculopathyLumbar radiculopathy patients (n=122), classified as ASA I to II without any symptoms of spinal cord compression (i.e. bilateral leg pain), who are scheduled for a first-time, single-level, unilateral lumbar discectomy.
Receives: Procedure: Lumbar discectomy
Healthy controlsSex, age, and BMI-matched healthy, pain-free control subjects (n=122) will be recruited for study participation.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quantitative sensory testing (QST) - electrical detection threshold

    Determination of sensory detection thresholds in response to electrical stimuli which are delivered transcutaneously over the n. suralis and n. medianus, recorded in mA.

    Measured: Change from baseline (T1) at 3 months after surgery (T2)

  2. Quantitative sensory testing (QST) - electrical pain threshold

    Determination of sensory pain threshold in response to electrical stimuli which are delivered transcutaneously over the n. suralis and n. medianus, recorded in mA.

    Measured: Change from baseline (T1) at 3 months after surgery (T2)

  3. Quantitative sensory testing (QST) - thermal detection threshold

    Determination of sensory detection thresholds in response to thermal stimuli which are delivered to the skin using a thermode, recorded in °C:

    • cold detection threshold
    • warmth detection threshold

    Measured: Change from baseline (T1) at 3 months after surgery (T2)

  4. Quantitative sensory testing (QST) - thermal pain threshold

    Determination of sensory pain thresholds in response to thermal stimuli which are delivered to the skin using a thermode, recorded in °C:

    • cold pain threshold
    • heat pain threshold

    Measured: Change from baseline (T1) at 3 months after surgery (T2)

  5. Quantitative sensory testing (QST) - discrimination between thermal stimuli

    Determination of the number of paradoxical heat sensations in response to alternating cold and warm stimuli delivered to the skin using a thermode.

    Measured: Change from baseline (T1) at 3 months after surgery (T2)

  6. Quantitative sensory testing (QST) - tactile detection threshold

    Determination of tactile detection threshold, assessed using Von Frey monofilaments, recorded in mN

    Measured: Change from baseline (T1) at 3 months after surgery (T2)

  7. Quantitative sensory testing (QST) - mechanical pain threshold

    Determination of mechanical pain threshold, assessed using pinprick stimulators, recorded in mN

    Measured: Change from baseline (T1) at 3 months after surgery (T2)

  8. Quantitative sensory testing (QST) - sensitivity to pressure stimuli

    Determination of pressure pain threshold, assessed using pressure algometry, recorded in kg

    Measured: Change from baseline (T1) at 3 months after surgery (T2)

  9. Quantitative sensory testing (QST) - temporal summation of electrical stimuli

    Determination of temporal summation in response to electrical stimuli delivered transcutaneously over the skin of the n. suralis and n. medianus.

    The numerical pain rating in response to these stimuli (range 0 - 100) will be recorded.

    Measured: Change from baseline (T1) and 3 months after surgery (T2)

  10. Quantitative sensory testing (QST) - temporal summation of mechanical stimuli

    Determination of temporal summation in response to mechanical stimuli delivered using a 256mN pinprick stimulator.

    The numerical pain rating in response to these stimuli (range 0 - 100) will be recorded.

    Measured: Change from baseline (T1) and 3 months after surgery (T2)

  11. Quantitative sensory testing (QST) - spinal hyperexcitability

    Determination of spinal hyperexcitability using the nociceptive flexion reflex (NFR; sensitization of spinal cord neurons), recorded in mA

    Measured: Change from baseline (T1) and 3 months after surgery (T2)

  12. Quantitative sensory testing (QST) - temporal summation of spinal hyperexcitability

    Determination of temporal summation of the nociceptive flexion reflex (NFR; sensitization of spinal cord neurons), recorded using a numeric pain rating scale (range 0 - 100)

    Measured: Change from baseline (T1) and 3 months after surgery (T2)

  13. Quantitative sensory testing - conditioned pain modulation

    Determination of condition pain modulation (aka. pain inhibits pain) by means of a heterotopic noxious counterstimulation paradigm. Test stimuli comprise of pressure pain threshold assessments and application of a heat stimulus (using a thermode) corresponding to a temperature eliciting a visual analog scale rating of 5/10. Test stimuli will be applied before, during and after the conditioning stimulus which is the immersion of the hand in a hot circulating water bath of 45.5°C.

    Measured: Change from baseline (T1) and 3 months after surgery (T2)

Secondary outcomes (20)
  1. Central sensitization inventory

    Self-report measure of signs and symptoms associated with central sensitization

    Measured: Baseline (T1)

  2. Central sensitization inventory

    Self-report measure of signs and symptoms associated with central sensitization

    Measured: 3 months after surgery (T2)

  3. Douleur Neuropathique 4 Questionnaire

    Clinician administered questionnaire for evaluation of signs and symptoms associated with neuropathic pain

    Measured: Baseline (T1)

  4. Douleur Neuropathique 4 Questionnaire

    Clinician administered questionnaire for evaluation of signs and symptoms associated with neuropathic pain

    Measured: 3 months after surgery (T2)

  5. Pain catastrophizing scale

    Self-report measure of pain perceptions and cognitions

    Measured: Baseline (T1)

  6. Pain catastrophizing scale

    Self-report measure of pain perceptions and cognitions

    Measured: 3 months after surgery (T2)

  7. Pain vigilance and awareness questionnaire

    Self-report measure assessing preoccupation with and attention to pain

    Measured: Baseline (T1)

  8. Pain vigilance and awareness questionnaire

    Self-report measure assessing preoccupation with and attention to pain

    Measured: 3 months after surgery (T2)

  9. Oswestry disability index

    Self-report measure evaluating low back pain related disability

    Measured: Baseline (T1)

  10. Oswestry disability index

    Self-report measure evaluating low back pain related disability

    Measured: 3 months after surgery (T2)

  11. Tampa scale for kinesiophobia

    Self-report measure assessing fear of movement

    Measured: Baseline (T1)

  12. Tampa scale for kinesiophobia

    Self-report measure assessing fear of movement

    Measured: 3 months after surgery (T2)

  13. International physical activity questionnaire

    Self-report measure of physical activity in preceeding 7 days

    Measured: Baseline (T1)

  14. International physical activity questionnaire

    Self-report measure of physical activity in preceeding 7 days

    Measured: 3 months after surgery (T2)

  15. Patient-reported outcomes measurement information system

    Self-report measure of health-related domains including:

    • physical functioning
    • anxiety
    • depression
    • fatigue
    • sleep disruption
    • participation in social activities
    • pain interference

    Measured: Baseline (T1)

  16. Patient-reported outcomes measurement information system

    Self-report measure of health-related domains including:

    • physical functioning
    • anxiety
    • depression
    • fatigue
    • sleep disruption
    • participation in social activities
    • pain interference

    Measured: 3 months after surgery (T2)

  17. Brief Illness Perception Questionnaire

    Self-report measure evaluating illness perceptions

    Measured: Baseline (T1)

  18. Brief Illness Perception Questionnaire

    Self-report measure evaluating illness perceptions

    Measured: 3 months after surgery (T2)

  19. Pain Coping Inventory

    Self-report measure assessing pain coping strategies

    Measured: Baseline (T1)

  20. Pain Coping Inventory

    Self-report measure assessing pain coping strategies

    Measured: 3 months after surgery (T2)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2021
  2. Study start1 Oct 2021
  3. Primary completion31 Oct 2023
  4. Study completion31 Oct 2023

Why it stopped: Diffculty recruiting patients, limited timeframe to complete project

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05022251
Sponsor's protocol ID
BC-08041
Other IDs
3F014119
Acronym
DISC-PAIN
Status last verified
Dec 2023
First submitted
12 May 2021
Last updated
20 Dec 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Lumbar Radiculopathy and Central Sensitisation, run by University Ghent at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 20 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Diffculty recruiting patients, limited timeframe to complete project). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quantitative sensory testing (QST) - electrical detection threshold (time frame: Change from baseline (T1) at 3 months after surgery (T2)). The study lists 13 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in